Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Vaccine crawled time : 17:00 save search
Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress
Published: 2024-03-11 (Crawled : 17:00) - biospace.com/
ANIX P | $3.185 0.47% 0.47% 99K
|
Health Technology
|
| O: -1.23%
H: 2.18%
C: 0.62%
vaccine congress world presentation
Global Respiratory Disease Vaccine Market Set for Growth, Fueled by Aging Populations and Vaccine Mandates - Trends, Opportunities, and Forecasts, 2018-2028F
Published: 2024-01-22 (Crawled : 17:00) - prnewswire.com
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: 1.71%
H: 0.0%
C: -0.15%
AZNCF | $138.88 -4.19% 960
|
Health Technology
|
| O: 2.63%
H: 0.8%
C: 0.75%
JNJ | $147.59 0.05% 0.0% 8.5M
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: 0.0%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: 0.0%
AZN | $68.75 -0.26% -0.26% 7.6M
|
Health Technology
|
| O: 1.8%
H: 0.14%
C: -0.89%
disease vaccine respiratory global set market
Transgene and NEC Extend their Collaboration to Continue Joint Clinical Development of Neoantigen Cancer Vaccine TG4050
Published: 2024-01-08 (Crawled : 17:00) - globenewswire.com
NIPNF | $74.3 -52.94% 290
|
Technology Services
| Email alert
Add to watchlist
tg4050 vaccine cancer collaboration
Global mRNA Vaccine Market Research Report 2023: On-going … – Business Wire
Published: 2023-11-03 (Crawled : 17:00) - spacfeed.com
HEPA | $2.145 -2.05% -2.1% 10K
|
Health Technology
|
| O: 4.29%
H: 2.57%
C: -2.04%
report vaccine business mrna research global market
Novavax's Updated Nuvaxovid™ COVID-19 Vaccine Receives Positive CHMP Opinion in the EU
Published: 2023-10-31 (Crawled : 17:00) - prnewswire.com
NVAX | $4.13 -3.51% -3.63% 5.3M
|
Health Technology
|
| O: -0.46%
H: 5.24%
C: 2.62%
covid-19 chmp vaccine positive
FDA Finds No Misconduct by Care Access in Pfizer’s Lyme Vaccine Trial
Published: 2023-10-11 (Crawled : 17:00) - biospace.com/
ARVL | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 6.48%
H: 4.35%
C: -5.22%
fda vaccine care trial
Esperovax Awarded $1M for Development of an Oral COVID-19 RNA Vaccine under the HHS Project NextGen Initiative
Published: 2023-10-03 (Crawled : 17:00) - biospace.com/
JNJ | $147.59 0.05% 0.0% 8.5M
|
Health Technology
|
| O: -0.26%
H: 0.53%
C: 0.43%
covid-19 initiative vaccine nextgen
Pfizer and BioNTech Receive Health Canada Authorization for XBB.1.5-Adapted Monovalent COVID-19 Vaccine
Published: 2023-09-28 (Crawled : 17:00) - globenewswire.com
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: -2.28%
H: 0.0%
C: -0.06%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -1.61%
H: 0.0%
C: 0.0%
BNTX | $87.88 1.62% 1.59% 750K
|
Health Technology
|
| O: 0.21%
H: 0.04%
C: -1.27%
covid-19 vaccine health authorization canada
Global Respiratory Syncytial Virus (RSV) Vaccine and Antibody Pipeline Market Forecasts to 2030
Published: 2023-09-15 (Crawled : 17:00) - prnewswire.com
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: 1.53%
H: 0.0%
C: 0.0%
AZNCF | $138.88 -4.19% 960
|
Health Technology
|
| O: 3.97%
H: 0.0%
C: 0.0%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
AZN | $68.75 -0.26% -0.26% 7.6M
|
Health Technology
|
| O: 1.27%
H: 0.38%
C: -0.54%
antibody vaccine respiratory pipeline global virus market
Europe Vaccine Packaging Market Insights Report 2023-2028: Breakdown by Primary, Secondary, & Tertiary Packaging - Focus on Vials, Ampoules, & Syringes
Published: 2023-07-03 (Crawled : 17:00) - prnewswire.com
BDX | $234.72 -0.19% 0.0% 830K
|
Health Technology
|
| O: -0.84%
H: 0.55%
C: 0.05%
europe report vaccine market
Assessment of Human DNA Vaccine Markets to 2028 by Mode of Administration, Application, End-user and Region
Published: 2023-06-23 (Crawled : 17:00) - prnewswire.com
VTRS | $11.32 -0.09% -0.09% 4.4M
|
Health Technology
|
| O: -2.79%
H: 1.23%
C: -0.1%
ZTS | $149.77 -0.14% 0.47% 8.3M
|
Health Technology
|
| O: -0.62%
H: 0.34%
C: -0.43%
vaccine dna
Transgene to Host KOL Webinar on TG4050: an Individualized Cancer Vaccine for the Treatment of HPV-Negative Head & Neck Cancers
Published: 2023-04-04 (Crawled : 17:00) - biospace.com/
NIPNF | $74.3 -52.94% 290
|
Technology Services
| Email alert
Add to watchlist
tg4050 vaccine cancer treatment
J&J reports second HIV vaccine regimen failure in 18 months – Endpoints News
Published: 2023-01-18 (Crawled : 17:00) - spacfeed.com
TSOI | $0.0008 0.0% 1.7M
|
Manufacturing
|
| O: 4.29%
H: 0.0%
C: -5.48%
vaccine hiv
U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine in Infants and Children
Published: 2023-01-06 (Crawled : 17:00) - biospace.com/
PFE A | $25.91 0.19% -0.04% 34M
|
Health Technology
|
| O: 0.64%
H: 3.24%
C: 1.88%
fda children vaccine application license review pneumococcal
CureVac Announces Positive Data on Joint COVID-19 and Flu mRNA Vaccine Development Programs
Published: 2023-01-06 (Crawled : 17:00) - biospace.com/
CVAC | $2.65 -8.94% -9.81% 940K
|
Health Technology
|
| O: 12.7%
H: 15.44%
C: 14.88%
covid-19 vaccine mrna positive
Akston Biosciences Announces Positive Interim Phase II Results from COVID “Universal” Booster Vaccine Trial
Published: 2022-11-01 (Crawled : 17:00) - biospace.com/
JNJ | $147.59 0.05% 0.0% 8.5M
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
covid vaccine trial positive results
Pfizer Heads to FDA with 85% Efficacy in RSV Vaccine for Older Adults
Published: 2022-08-25 (Crawled : 17:00) - biospace.com/
JNJ | $147.59 0.05% 0.0% 8.5M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
fda vaccine
Takeda’s QDENGA®▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved in Indonesia for Use Regardless of Prior Dengue Exposure
Published: 2022-08-22 (Crawled : 17:00) - biospace.com/
TAK | $13.18 -1.42% 0.0% 1.8M
|
Health Technology
|
| O: -1.01%
H: 1.16%
C: 0.44%
qdenga vaccine approved qdengue
U.S. Government Orders Another 2.5 Million Doses of Monkeypox Vaccines from Bavarian Nordic
Published: 2022-07-15 (Crawled : 17:00) - globenewswire.com
JNJ | $147.59 0.05% 0.0% 8.5M
|
Health Technology
|
| O: 2.88%
H: 0.0%
C: 0.0%
monkeypox vaccine
Valneva Receives Marketing Authorization in Europe for Inactivated Whole-Virus COVID-19 Vaccine VLA2001
Published: 2022-06-24 (Crawled : 17:00) - globenewswire.com
DVAX | $11.69 -1.27% -1.28% 1.9M
|
Health Technology
|
| O: -0.65%
H: 1.52%
C: 1.07%
covid-19 valneva europe vaccine vla2001 authorization
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.94 49.23% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
AMBI | $3.72 -26.77% 21.77% 9.8K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.